Oxylo, Inc.
San Diego, CA
- UEI
- TZGHKYLCLET4
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 9805 Jake Ln, San Diego, CA 92126, USA
- Website
- oxylobio.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Oxygen reducing microcapsules for in vitro control of hypoxia | National Institute of General Medical Sciences (NIH) | $1,061,748 |
Quick answers
Is Oxylo, Inc. registered in SAM.gov?
Yes. Oxylo, Inc.'s SAM.gov registration is active through December 29, 2026.
What is Oxylo, Inc.'s most recent federal award?
Oxylo, Inc.'s most recent federal grant award is Oxygen reducing microcapsules for in vitro control of hypoxia (R44GM159549), from National Institute of General Medical Sciences (NIH), on August 1, 2025.
On GovTribe
See Oxylo, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors